Search results
A growing body of literature demonstrates that aggressive LDL-C lowering can reverse early atherosclerosis, regress advanced plaque, and reduce near- and long-term ASCVD risk. For example, in several animal models LDL-C lowering has been shown to regress and, in some cases, reverse atherosclerotic plaque and improve vascular function 45 , 46 .
- Emerging Therapies for the Treatment of Atherosclerotic Cardiovascular ...
Apart from lifestyle interventions (such as smoking...
- Emerging Anti-Atherosclerotic Therapies - PMC - National Center for ...
Introduction. Cardiovascular disease (CAD) is a serious...
- Emerging Therapies for the Treatment of Atherosclerotic Cardiovascular ...
If atherosclerosis causes a severe blockage in an artery, you may need a procedure or surgery to treat it. Surgery or procedures for atherosclerosis may include: Angioplasty and stent placement, also called percutaneous coronary intervention. This treatment helps open a clogged or blocked artery.
24 mar 2022 · In this circumstance, inevitably, targeting these processes is considered to be effective for treating atherosclerosis. Arriving, retention and working of payload candidates mediated by targets in lesion direct ultimate therapeutic outcomes.
29 kwi 2023 · Apart from lifestyle interventions (such as smoking cessation, physical activity, and diet), the current cornerstone in atherosclerosis prevention is treating the dyslipidemia with statins and, to a lesser extent, with ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors . Considering the suboptimal results of ...
9 lis 2021 · Introduction. Cardiovascular disease (CAD) is a serious health problem and the main cause of death and morbidity in the western world [1, 2]. Atherosclerosis, which begins early in human life and is influenced by maternal risk factors, underlies CAD development [3, 4].
31 sty 2022 · In this Review, we provide an overview of the role of the immune system in atherosclerosis by discussing findings from preclinical research and clinical trials.
11 maj 2021 · Atherosclerosis, a dominant and growing cause of death and disability worldwide, involves inflammation from its inception to the emergence of complications. Targeting inflammatory pathways could...
